Ledger.Open graph →
SEC Form D · filed March 11, 2026

Everest Biolabs, Inc

Offering
$5.7M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

David Freedman · Tempe, AZExec · DirectorPaul Meister · High Point, NCDirectorVinit Nijhawan · Cambridge, MADirectorGeorge Daaboul · Boston, MAExec · DirectorDavid Walt · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗